Insiders Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 13/09/2024 pm IST			5-day change	1st Jan Change
918.50 ^DKK	+0.47%		+4.20%	+31.57%

13/09	Eli Lilly invests $1.8 billion in Ireland sites to scale up Alzheimer's, obesity drug production	RE
12/09	NOVO NORDISK : Deutsche Bank keeps its Buy rating	ZD

Health Care Declines as Risk Aversion Weighs - Health Care Roundup	06/09	DJ
Lars Fruergaard Jorgensen, CEO of Novo Nordisk on guidance, Wegovy and US Market	07/08	MT
Sagimet Biosciences Inc. Announces Appointment of Board of Directors	01/08	CI
SpringWorks Therapeutics, Inc. Appoints Dr. Martin Mackay to Its Board of Directors	29/07	CI
Hims & Hers Health, Inc. Announces Appointment of Kåre Schultz to Board of Directors	22/07	CI
A weight loss ETF	18/06	MT
Adocia appoints Director of Operations	04/06	CF
Novo Nordisk CEO: Demand for Wegovy outstrips supply	02/05	MT
Germany's Evotec appoints Christian Wojczewski as CEO	24/04	RE
Kasim Kutay, CEO of Novo Holdings: Catalent purchase marks new era of acquisitions	12/03	MT
Global markets live: Darktrace, Merck, Meta, Apple, Eli Lilly...	07/03
WeightWatchers shares drop as Oprah Winfrey decides to exit board	29/02	RE
Novo Nordisk CEO Jorgensen: Demand will outstrip supply for years to come	08/02	MT
Jorgensen, CEO of Novo Nordisk: €10bn investment to meet demand for its weight loss drugs	31/01	MT
Evotec says it promptly reported share trades withheld by former CEO	22/01	RE
Kasim Kutay, CEO of Novo Holdings: Acquisition Offensive	19/01	MT
A new ETF dedicated to anti-obesity drugs (Ozempic, Mounjaro, Wegovy)!	28/11	MT
Lars Fruergaard Jorgensen, CEO of Novo Nordisk: dose limitation to continue until 2024	02/11	MT
Novo Says Wegovy Is Growth Driver in US	02/11	MT
Recordati, Zdravkovic vice president R&D and Sabia new CMO	16/23/16	AN